Received Aug 1, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (HEPLISAV-B) | DYNAVAX TECHNOLOGIES CORPORATION | 5 | 946889 | IM / LA |
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | 2 | Y020516 | SC / LA |
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | 5 | KR75K | IM / RA |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | 1 | Z003766 | SC / RA |
Patient received a 5th dose of HepB which was not warranted. Patient did not have no adverse reaction from additional dose of HepB vaccine. Patient was in clinic with a list of vaccines needed.
none reported
none reported
none reported
none reported
n/a